Patent Term Extension Application for NEXVIAZYME® (avalglucosidase alfa-ngpt), Patent No. 8,759,501 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2024-E-5945

Patent Term Extension Application for NEXVIAZYME® (avalglucosidase alfa-ngpt), Patent No. 8,759,501

Documents

Comments

Description

Open

Comment Period OpensDec 30, 2024

Type	Title	Posted	Comments	Status
Other	Letter from U.S Patent and Trademark Office to FDA CDER	Mar 25, 2026	--

CDER

Patent Term Extension Application

Patent No. 8,759,501

NEXVIAZYME® (avalglucosidase alfa-ngpt)

Genzyme Corp.

Covington & Burling LLP

Open